Penn researchers identify potential target for breast cancer therapy
Wednesday, December 22, 2010 - 14:51
in Health & Medicine
PHILADELPHIA -- Overexpression or hyperactivation of ErbB cell-surface receptors drives the growth of many breast cancers. Drugs, like Herceptin, that block the receptors' signals halt tumor...
